Madrigal Pharmaceuticals, Inc.
MDGLNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $12.66B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $393.61$615.00
- Volume (live)
- -
- Avg. volume (3M)
- 278.81K
Madrigal Pharmaceuticals (MDGL) Stock Price & Financial Analysis
Madrigal Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $433.31 - $453.55 |
|---|---|
| 52-Week High | $615.00 |
| 52-Week Low | $393.61 |
| Open | $453.55 |
| Volume (last close) | 234.83K |
| Average Volume (3M) | 278.81K |
| Revenue (TTM) | 1.28B |
|---|---|
| Net Income (TTM) | -325.10M |
| Free Cash Flow (TTM) | -206.28M |
| EPS (TTM) | −$12.61 |
| Profit Margin | -25.32% |
| Operating Margin | -25.13% |
| Return on Equity (ROE) | -62.07% |
| Debt to Equity | 0.66 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 12.66B |
|---|---|
| Shares Outstanding | 29.15M |
| Price to Sales (P/S) | 9.86 |
| Price to Book (P/B) | 24.17 |
| EV/EBITDA | -43.36 |
| 50-Day MA | $512.23 |
|---|---|
| 200-Day MA | $503.80 |
| 1-Year Change | +6.95% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Madrigal Pharmaceuticals at a Glance
As of the Oct 23, 2026 close, Madrigal Pharmaceuticals (MDGL) has a market capitalization of $12.66B. The stock trades at 9.9× sales. Over the trailing twelve months it lost $325.10M on revenue of $1.28B and burned $206.28M of free cash flow. Revenue grew 149.0% year over year.
As of its latest reported balance sheet, it holds $292.73M in cash and securities against $347.75M of debt, a net debt position of $55.02M.
Madrigal Pharmaceuticals does not currently pay a dividend.
The share price is up 7.0% over the past year. At $434.24 (the Oct 23, 2026 close) it sits within its 52-week range of $393.61 to $615.00, below its 200-day moving average of $503.80.
Based on 13 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $683.67, 57.4% above the Oct 23, 2026 close.
Frequently Asked Questions About Madrigal Pharmaceuticals
What is the current stock price for MDGL?
As of the Oct 23, 2026 close, MDGL stock trades at $434.24. The 52-week range is $393.61–$615.00, with a day range of $433.31–$453.55.
What is the P/E ratio for MDGL?
The P/E ratio (Price-to-Earnings) for MDGL is shown in the Key Statistics section. This valuation metric helps compare Madrigal Pharmaceuticals, Inc. to industry peers.
Does MDGL pay dividends?
Madrigal Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for MDGL?
Based on ratings from 13 professional analysts over the last 90 days, the consensus for MDGL is Buy. The average 12-month price target is $683.67, a 57.4% upside from the Oct 23, 2026 close of $434.24.
What is the market cap of MDGL?
As of the Oct 23, 2026 close, Madrigal Pharmaceuticals's market capitalization is $12.66B, classifying it as a large-cap company. Madrigal Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.